Cranbrook Wealth Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-93
Closed -$6.68K – 415
2026
Q2
$6.68K Hold
93
– – ﹤0.01% 324
2026
Q1
$11K Sell
93
-55
-37% -$6.8K ﹤0.01% 284
2025
Q4
$18.6K Hold
148
– – ﹤0.01% 251
2025
Q3
$21.7K Sell
148
-38
-20% -$5.74K ﹤0.01% 245
2025
Q2
$29K Hold
186
– – 0.01% 222
2025
Q1
$30.6K Hold
186
– – 0.01% 210
2024
Q4
$30.3K Buy
186
+55
+42% +$9.8K 0.01% 211
2024
Q3
$25.6K Hold
131
– – 0.01% 215
2024
Q2
$22.7K Buy
+131
New +$21.8K 0.01% 216
2022
Q1
– Sell
-30
Closed -$7K – 374
2021
Q4
$7K Hold
30
– – ﹤0.01% 307
2021
Q3
$6K Buy
+30
New +$6.05K ﹤0.01% 330

Other funds holding ZTS

Cranbrook Wealth Management's ZTS Position: Q3 2026 in Review

Cranbrook Wealth Management sold out of Zoetis (ZTS) in Q3 2026, closing a stake of 93 shares — an estimated $6.68K sold.

Cranbrook Wealth Management first reported a position in ZTS in Q3 2021 and held it in 11 quarters. The position peaked at $30.6K in Q1 2025. 867 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Cranbrook Wealth Management reported no remaining Zoetis position as of Q3 2026 after selling out during the quarter.
  • Cranbrook Wealth Management sold 93 Zoetis shares in Q3 2026, an estimated $6.68K.
  • Cranbrook Wealth Management first reported a position in Zoetis in Q3 2021 and held it in 11 quarters.
  • Cranbrook Wealth Management's Zoetis position peaked at $30.6K in Q1 2025.
  • 867 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.